FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Luke Hughes-Davies

Research Profile

Chemicals & Drugs

Concepts & Ideas

Phenomena

Co-author Network

Publications

TOP 3
Ali Naderi; Luke Hughes-Davies
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.
Gayatri B Chavali; Caroline M S Ekblad; Balaku P Basu; Nigel C Brissett; Dmitry B Veprintsev; Luke Hughes-Davies; Tony Kouzarides; Laura S Itzhaki; Aidan J Doherty
Crystal structure of the ENT domain of human EMSY.
Caroline M S Ekblad; Gayatri B Chavali; Balaku P Basu; Stefan M V Freund; Dmitry B Veprintsev; Luke Hughes-Davies; Tony Kouzarides; Aidan J Doherty; Laura S Itzhaki
Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Luke Hughes-Davies (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Ali Naderi; Luke Hughes-Davies
A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.
Neoplasia (New York, N.Y.) 2008;10(6):542-8.
2005: Gayatri B Chavali; Caroline M S Ekblad; Balaku P Basu; Nigel C Brissett; Dmitry B Veprintsev; Luke Hughes-Davies; Tony Kouzarides; Laura S Itzhaki; Aidan J Doherty
Crystal structure of the ENT domain of human EMSY.
Journal of molecular biology 2005;350(5):964-73.
2005: Caroline M S Ekblad; Gayatri B Chavali; Balaku P Basu; Stefan M V Freund; Dmitry B Veprintsev; Luke Hughes-Davies; Tony Kouzarides; Aidan J Doherty; Laura S Itzhaki
Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69.
EMBO reports 2005;6(7):675-80.
2004: Carmen Rodriguez; Luke Hughes-Davies; Hélène Vallès; Béatrice Orsetti; Marguerite Cuny; Lisa Ursule; Tony Kouzarides; Charles Theillet
Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5785-91.
2003: Luke Hughes-Davies; David Huntsman; Margarida Ruas; François Fuks; Jacqueline Bye; Suet-Feung Chin; Jonathon Milner; Lindsay A Brown; Forrest Hsu; Blake Gilks; Torsten Nielsen; Michael Schulzer; Stephen Chia; Joseph Ragaz; Anthony Cahn; Lori Linger; Hilal Ozdag; Elena Cattaneo; Ekaterina S. Jordanova; Edward Schuuring; David S Yu; Ashok R Venkitaraman; Bruce A J Ponder; Aidan Doherty; Samuel A J R Aparicio; David Bentley; Charles Theillet; Chris P Ponting; Carlos Caldas; Tony Kouzarides
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
Cell 2003;115(5):523-35.
2003: Sebastian Maurer-Stroh; Nicholas J Dickens; Luke Hughes-Davies; Tony Kouzarides; Frank Eisenhaber; Chris P Ponting
The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains.
Trends in biochemical sciences 2003;28(2):69-74.
2001: C D Lücke; Anna Philpott; James C Metcalfe; A M Thompson; Luke Hughes-Davies; Paul R Kemp; Robin Hesketh
Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.
Cancer research 2001;61(2):482-5.
2000: Jonathon Milner; François Fuks; Luke Hughes-Davies; Tony Kouzarides
The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase.
Oncogene 2000;19(38):4441-5.
2000: François Fuks; Wendy A Burgers; A Brehm; Luke Hughes-Davies; Tony Kouzarides
DNA methyltransferase Dnmt1 associates with histone deacetylase activity.
Nature genetics 2000;24(1):88-91.
1997: Jonathon Milner; Bruce A J Ponder; Luke Hughes-Davies; M Seltmann; Tony Kouzarides
Transcriptional activation functions in BRCA2.
Nature 1997;386(6627):772-3.